STOCK TITAN

Clover Health Investments, Corp - CLOV STOCK NEWS

Welcome to our dedicated page for Clover Health Investments news (Ticker: CLOV), a resource for investors and traders seeking the latest updates and insights on Clover Health Investments stock.

Clover Health Investments, Corp. (NASDAQ: CLOV) is a physician enablement company dedicated to bringing high-quality, affordable healthcare to seniors, particularly those who have historically faced barriers to access. By leveraging its proprietary platform, Clover Assistant, Clover Health empowers physicians to make data-driven, personalized decisions, enhancing patient outcomes while reducing unnecessary costs.

Operating primarily through its Insurance and Non-Insurance segments, Clover Health offers a variety of Medicare Advantage plans, including PPO and HMO options. Through the Insurance segment, Clover Health delivers comprehensive healthcare coverage to members across multiple states. Its Non-Insurance segment participates in the ACO REACH Model, reinforcing its commitment to value-based care.

Clover Assistant aggregates patient data from across the healthcare ecosystem and provides real-time, personalized recommendations at the point of care. This tool has proven effective in improving medication adherence and managing chronic conditions, such as diabetes, high blood pressure, and high cholesterol, ultimately enhancing clinical outcomes.

Recent achievements highlight Clover Health's strategic focus and operational success. The company has demonstrated significant progress in improving medication adherence through the use of Clover Assistant. Additionally, Clover Health is targeting Adjusted EBITDA profitability for the full year of 2024, driven by strong performance in their Medicare plans and strategic investments in technology and care management.

Partnership efforts, such as those with Quartet Health, aim to enhance care delivery for underserved and high-risk patient populations through Clover's home-based care model. This initiative is part of Clover Health's broader strategy to improve health equity and provide comprehensive, coordinated care.

With a steadfast commitment to making care accessible and ensuring patients have the freedom to choose their doctors, Clover Health continues to drive innovation in healthcare. For more information about Clover Assistant, visit Clover Assistant.

Stay updated on the latest developments and strategic moves by Clover Health by following their news updates:

  • Higher fill rates result in improved performance on medication adherence quality measures in the Medicare Advantage Stars program for members where Clover Assistant was used (January 8, 2024)
  • Clover Health targeting Adjusted EBITDA profitability for the full-year 2024 (January 10, 2024)
  • Clay Thornton appointed Chief Financial Officer of Medicare Advantage division (March 7, 2024)
  • Partnership with Quartet Health to enhance home-based care delivery (February 5, 2024)
  • Counterpart Assistant now available for external payors and providers (May 29, 2024)
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) released research demonstrating Clover Assistant’s impact on medication adherence in the Medicare Advantage Stars program. The study examined the correlation between PCP use of Clover Assistant and levels of adherence to prescribed medications for common chronic conditions. Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant, highlighted the importance of medication adherence for chronic health conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
none
-
Rhea-AI Summary
Clover Health Investments, Corp. (Nasdaq: CLOV) announced that its Chief Financial Officer, Scott J. Leffler, will be leaving the company to pursue another professional opportunity. The company has initiated a search for a successor CFO, with Lee A. Shapiro, Chair of the Audit Committee, leading the search committee. The company has engaged a leading executive search firm to assist in finding a new CFO for the next stage of its growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) announced that its CEO, Andrew Toy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024, at 12:00 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.92%
Tags
conferences
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) has announced its decision to exit the CMS ACO REACH Program at the end of the 2023 performance year. The company will continue to fulfill its obligations for the 2023 performance year, with no impact on its ACO REACH beneficiaries. CEO Andrew Toy stated that the decision was made due to a lack of clear profitability in the ACO REACH business, and the company's focus on profitability in its Medicare Advantage insurance business.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
none
-
Rhea-AI Summary
Clover Health and WellBe Senior Medical have partnered to provide home-based medical care to Georgia residents with complex health conditions, offering in-home visits, personalized care plans, and access to community resources.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.14%
Tags
partnership
-
Rhea-AI Summary
Clover Health Investments, Corp. reported its financial results for the third quarter of 2023. The company's insurance revenue grew by 12% compared to Q3 2022, reaching $301.2 million. The medical care ratio (MCR) for insurance improved to 78.5% from 86.3%. Non-insurance revenue declined by 70% to $176.0 million. The net loss for the quarter was $41.5 million, and adjusted EBITDA loss improved to $5.1 million compared to the same period last year. The revised full-year 2023 guidance reflects an insurance MCR of 81% - 82% and adjusted EBITDA of ($55) million - ($80) million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.14%
Tags
Rhea-AI Summary
Clover Health has announced the appointment of Karen Soares as General Counsel. Soares has been with Clover since 2018 and has served in various legal and compliance positions. She will report to Andrew Toy, CEO of Clover.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
none
-
Rhea-AI Summary
Clover Health Investments, Corp. to report third quarter 2023 financial results on November 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
conferences earnings
-
Rhea-AI Summary
Clover Health's analysis shows that the use of Clover Assistant leads to earlier diagnosis and treatment of diabetes, resulting in improved patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
none
Rhea-AI Summary
Clover Health CEO to participate in fireside chat at Maxim Group conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
conferences acquisition

FAQ

What is the current stock price of Clover Health Investments (CLOV)?

The current stock price of Clover Health Investments (CLOV) is $3.23 as of December 20, 2024.

What is the market cap of Clover Health Investments (CLOV)?

The market cap of Clover Health Investments (CLOV) is approximately 1.6B.

What does Clover Health do?

Clover Health is a physician enablement company that focuses on providing affordable, high-quality healthcare for seniors, particularly those on Medicare.

What is Clover Assistant?

Clover Assistant is Clover Health's proprietary software platform designed to aggregate patient data and provide real-time, personalized recommendations to physicians.

How does Clover Health generate revenue?

Clover Health primarily generates revenue through its Insurance segment by offering Medicare Advantage plans. A smaller portion comes from the Non-Insurance segment, which participates in the ACO REACH Model.

What recent achievements has Clover Health made?

Recent achievements include improving medication adherence rates through Clover Assistant and targeting Adjusted EBITDA profitability for the full year of 2024.

What types of Medicare Advantage plans does Clover Health offer?

Clover Health offers both PPO and HMO Medicare Advantage plans.

What is the significance of Clover Health's partnership with Quartet Health?

The partnership aims to enhance care for underserved and high-risk populations through Clover's home-based care model, improving both physical and behavioral health outcomes.

How does Clover Assistant benefit physicians?

Clover Assistant provides real-time, data-driven insights to physicians, aiding in early detection and management of chronic diseases, ultimately improving patient care.

What is the focus of Clover Health's Non-Insurance segment?

The Non-Insurance segment focuses on value-based care models, including participation in the ACO REACH Model.

What are Clover Health's future goals?

Clover Health aims to achieve Adjusted EBITDA profitability for the full year of 2024 and expand the reach of Clover Assistant through its Counterpart Assistant initiative.

How does Clover Health improve healthcare accessibility?

Clover Health is committed to making healthcare accessible by offering affordable Medicare Advantage plans and ensuring patients can choose their preferred doctors.

Clover Health Investments, Corp

Nasdaq:CLOV

CLOV Rankings

CLOV Stock Data

1.59B
388.41M
5.33%
20.16%
3.28%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
FRANKLIN